NEW YORK (360Dx) – Atomo Diagnostics and Access Bio said today that they would leverage their rapid diagnostic testing technology as part of a collaboration that takes aim at expanding point-of-care HIV testing in global markets.

Atomo will supply its AtomoRapid lateral flow platform for use with an Access Bio rapid test that detects the presence of HIV antibodies in a single drop of blood obtained from a fingertip. The test result can be read in minutes, which is essential to enabling same-day diagnosis and early treatment, the firms said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05
Sponsored by
Linguamatics

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.